Cardiovascular stents - Biomaterials and Devices for the Circulatory System - page 200

• British Heart Foundation statistics data base www.heartstats.org.
• A full description of the anatomy of blood vessels can be found in
Human Anatomy and Physiology , third edition, Elaine N. Marieb.
• Bonan R and Asgar AW (2009) Biodegradable stents - Where are we
in 2009? US Cardiology , 6 : H 81-84.
• Arab A, Bode C and Hehrlein C (2001) The radioactive stent - any
chance of a resurrection? European Heart Journal , 22 : 1245-1247.

• Shabalovska SA (2002) Surface, corrosion and biocompatibility aspects

of nitinol as an implant material. Bio-Medical Materials and Engineer-
ing , 1 2 : 69-109.

• O'Brien B and Carroll W (2009) The evolution of cardiovascular stent

materials and surfaces in response to clinical drivers: A review. Acta
Biomateriala , 5 : 945-958.

• Mani G, Feldman MD, Patel D, Agrawal CM (2007) Coronary stents: a

materials perspective. Biomaterials , 28 : 1689-1710.

7.10 References
ABIZAID A, POPMA JJ, TANAJURA LF, HATTORI K, SOLBERG B, LARRACAS C, FERES F, COSTA
JD and SCHWARTZ LB. Clinical and angiographic results of percutanious coronary
revascularisation using a trilayer stainless steel-tantalum-stainless steel phos-
phorylcholine-coated stent: The Trimaxx trial. Cathet Cardiovasc Interven 2007;
70 (7): 914-919.
AIROLDI F, COLOMBO A, TAVENO D, STANKOVIC G, KLUGMANN S, PAOLILLO V, BONIZZONI
E, BRIGUORI C, CARLINO M, MONTORFANO M, LIISTRO F, CASTELLI A, FERRARI A, SGURA F
and DI MARIO C. Comparison of diamond-like carbon coated stents versus uncoated
stainless steel stents in coronary artery disease. Am J Cardiol 2004; 93 : 474-477.
ALBIERO R, ADAMIAN M, KOBAYASHI N, et al. Short and intermediate-term results of
32P radioactive β-emitting stent implantation in patients with coronary artery
disease. Circulation 2000a; 101 : 18-26.
ALBIERO R, NISHIDA T, ADAMIAN M et al. Edge restenosis after implantation of high
activity 32P radioactive β-emitting stents. Circulation 2000b; 101 : 2454-2460.
AL-LAMEE K. Surface modifi cation of stents for improving biocompatibility. Medical
Device Technol 2000; 11 : 12-20.
ALT E and SCHÖMIG A. The infl ow coronary stent. In: Serruys PW, Kutryk MJB,
editors. Handbook of Coronary Stents . London: Martin Dunitz; 1998; 265-273.
AMERICAN HEART ASSOCIATION (AHA). Heart disease and Stroke Statistics: 2009 Update .
2009.
ANTONIUCCI D, BARTORELLI A, VALENTI R, MONTORSI P, SANTORO GM, FABBIOCCHI F, BOLOG-
NESE L, LOALDI A, TRAPANI M, TRABATTONI D, MOSCHI G and GALLI S. Clinical and
angiographic outcome after coronary arterial stenting with the carbostent. Am J
Cardiol 2000; 85 : 821-835.
ANTONIUCCI D, VALENTI R, MIGLIORINI A, MOSCHI G, TRAPANI M, BOLOGNESE L, SANTORO
GM and CERISANO G. Clinical and angiographic outcomes following elective implan-
tation of the carbostent in patients at high risk of restenosis and target vessel
failure. Cathet Cardiovsc Interven 2001; 54 : 420-426.

￿ ￿ ￿ ￿ ￿